Ward JL, Azzopardi PS, Francis KL et al (2021) Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the global burden of disease study 2019. The Lancet 398:1593–1618

Article  Google Scholar 

Hofbauer LC, Busse B, Eastell R et al (2022) Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol 10:207–220

Article  PubMed  Google Scholar 

Behanova M, Haschka J, Zwerina J et al (2021) The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortality. Eur J Endocrinol 184:627–636

Article  CAS  PubMed  Google Scholar 

Kameda W, Daimon M, Oizumi T et al (2005) Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the fungata study. Metabolism 54:669–676

Article  CAS  PubMed  Google Scholar 

Brahimaj A, Muka T, Kavousi M et al (2017) Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the rotterdam study. Diabetologia 60:98–106

Article  CAS  PubMed  Google Scholar 

Liu L, Wang M, Yang X et al (2013) Fasting serum lipid and dehydroepiandrosterone sulfate as important metabolites for detecting isolated postchallenge diabetes: serum metabolomics via ultra-high-performance LC-MS. Clin Chem 59:1338–1348

Article  CAS  PubMed  Google Scholar 

Ghebre MA, Hart DJ, Hakim AJ et al (2011) Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study. Calcif Tissue Int 89:295–302

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szathmári M, Szũcs J, Fehér T et al (1994) Dehydroepiandrosterone sulphate and bone mineral density. Osteoporos Int 4:84–88

Article  PubMed  Google Scholar 

Tok EC, Ertunc D, Oz U et al (2004) The effect of circulating androgens on bone mineral density in postmenopausal women. Maturitas 48:235–242

Article  CAS  PubMed  Google Scholar 

Lambrinoudaki I, Christodoulakos G, Aravantinos L et al (2005) Endogenous sex steroids and bone mineral density in healthy greek postmenopausal women. J Bone Miner Metab 24:65–71

Article  Google Scholar 

Murphy S, Khaw K-T, Sneyd MJ et al (1992) Endogenous sex hormones and bone mineral density among community-based postmenopausal women. Postgrad Med J 68:908–913

Article  CAS  PubMed  PubMed Central  Google Scholar 

Z̆ofková I, Bahbouh R, Hill M (2000) The pathophysiological implications of circulating androgens on bone mineral density in a normal female population. Steroids 65:857–861

Article  PubMed  Google Scholar 

Hosoda H, Fukui M, Nakayama I et al (2008) Bone mass and bone resorption in postmenopausal women with type 2 diabetes mellitus. Metabolism 57:940–945

Article  CAS  PubMed  Google Scholar 

Leslie WD, Aubry-rozier B, Lamy O et al (2013) TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab 98:602–609

Article  CAS  PubMed  Google Scholar 

Society C D (2021) Guideline for the prevention and treatment of type 2 diabetes mellitus in China. International Journal of Endocrinology and Metabolism, Chinese Medical Journals Publishing House Co. Ltd 41:482–548

Google Scholar 

Hypertension W G of 2018 C G for the M of, League C H, Cardiology C S of (2019) 2018 Chinese guidelines for the management of hypertension. Chinese Journal of Cardiovascular Medicine, Chinese Medical Journals Publishing House Co. Ltd 24:24–56

Google Scholar 

Adults J committee issued C guideline for the management of dyslipidemia in (2016) 2016 Chinese guideline for the management of dyslipidemia in adults. Chinese Journal of Cardiology, Chinese Medical Journals Publishing House Co Ltd 44:833–853

Google Scholar 

Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604

Article  PubMed  PubMed Central  Google Scholar 

Takahashi TA, Johnson KM (2015) Menopause. Med Clin North Am 99:521–534

Article  PubMed  Google Scholar 

Wang Y, Tao M, Cheng W et al (2012) Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway. Chin Med J 125:1230–1235

CAS  PubMed  Google Scholar 

Qiu X, Gui Y, Xu Y et al (2015) DHEA promotes osteoblast differentiation by regulating the expression of osteoblast-related genes and Foxp3(+) regulatory T cells. Biosci Trends 9:307–314

Article  CAS  PubMed  Google Scholar 

Zhang N, Gui Y, Qiu X et al (2016) DHEA prevents bone loss by suppressing the expansion of CD4(+) T cells and TNFa production in the OVX-mouse model for postmenopausal osteoporosis. Biosci Trends 10:277–287

Article  CAS  PubMed  Google Scholar 

Yokomoto-Umakoshi M, Umakoshi H, Iwahashi N et al (2021) Protective role of DHEAS in age-related changes in bone mass and fracture risk. J Clin Endocrinol Metab 106:e4580–e4592

Article  PubMed  Google Scholar 

Nunes E, Gallardo E, Morgado-Nunes S et al (2023) Steroid hormone levels and bone mineral density in women over 65 years of age. Sci Rep 13:4925

Article  CAS  PubMed  PubMed Central  Google Scholar 

Osmanaǧaoǧlu MA, Okumuş B, Osmanaǧaoǧlu T et al (2004) The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. Journal of Women’s Health 13:993–999

Article  PubMed  Google Scholar 

Quester J, Nethander M, Eriksson A et al (2022) Endogenous DHEAS is causally linked with lumbar spine bone mineral density and forearm fractures in women. J Clin Endocrinol Metab 107:e2080–e2086

Article  PubMed  Google Scholar 

Labrie F, Diamond P, Cusan L et al (1997) Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498–3505

Article  CAS  PubMed  Google Scholar 

Nair KS, Rizza RA, O’brien P et al (2006) DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647–1659

Article  CAS  PubMed  Google Scholar 

Weiss EP, Shah K, Fontana L et al (2009) Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr 89:1459–1467

Article  CAS  PubMed  PubMed Central  Google Scholar 

Von Mühlen D, Laughlin GA, Kritz-Silverstein D et al (2008) Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos Int 19:699–707

Article  Google Scholar 

Jankowski CM, Gozansky WS, Schwartz RS et al (2006) Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab 91:2986–2993

Article  CAS  PubMed  Google Scholar 

Baulieu E-E, Thomas G, Legrain S et al (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci 97:4279–4284

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jankowski CM, Wolfe P, Schmiege SJ et al (2019) Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: a pooled analysis of four clinical trials. Clin Endocrinol 90:293–300

Article  CAS  Google Scholar 

Longcope C (1996) Dehydroepiandrosterone metabolism. J Endocrinol 150:S125-127

CAS